Monday, January 23, 2017
Circulation Research, a Journal of the American Heart Association
Editorial: Is There a Role for Intravenous Stem Cell Delivery in Nonischemic Cardiomyopathy?
Dr. Jay H. Traverse, MD, FACC, FAHA, cited CardioCell’s Phase IIa chronic heart failure clinical trial results in an editorial in the January issue of the American Heart Association’s journal Circulation Research. His editorial “Is There a Role for Intravenous Stem Cell Delivery in Nonischemic Cardiomyopathy?” examines the potential benefits of intravenous delivered allogeneic stem cell therapy. Dr. Traverse is the Minneapolis Heart Institute Foundation’s Director of Research, the University of Minnesota School of Medicine’s Associate Professor of Medicine — Cardiovascular Division and a Senior Consulting Cardiologist for the Minneapolis Heart Institute at Abbott Northwestern Hospital; he is not associated with the CardioCell trial and had no disclosures to report.
The full article is available online at Circulation Research.